Crossmark

In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing Enterobacterales: cross-resistance and synergistic effects

Crossref DOI link: https://doi.org/10.1007/s10096-021-04341-z

Published Online: 2021-08-31

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bianco, Gabriele

Boattini, Matteo

Comini, Sara

Iannaccone, Marco

Bondi, Alessandro

Cavallo, Rossana

Costa, Cristina
License Information

Text and Data Mining valid from 2021-08-31

Version of Record valid from 2021-08-31
More Information

Article History

Received: 14 June 2021

Accepted: 24 August 2021

First Online: 31 August 2021

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki. Formal ethical approval was obtained by the center’s institutional review board.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below